Here are six highlights from Medtronic's recent investor day, according to a Seeking Alpha report.
1. Medtronic's goal is to generate $40 billion in free cash flow over the next five years, with half returned to shareholders as dividends and buybacks.
2. The company will allocate $10 billion of the $40 billion in free-cash-flow to debt reduction and bolt-on mergers and acquisitions. The remaining $10 is slated for flexible options including "bolstering the company's cash position."
3. Medtronic intends to achieve mid-single digit constant currency revenue growth in the next five years, as well as double-digit constant currency EPS.
4. Every Medtronic division plans to drive innovation and new product development. While the cardiac and vascular market is expected to grow at a 4 percent CAGR, the company wants to grow at a 9 percent CAGR.
5. Medtronic is benefiting from its Covidien merger and a marginally lower tax rate from relocating headquarters from the United States to Ireland; which has resulted in a 200 to 300 bps.
6. Medtronic will likely have access to 75 percent of the ongoing free-cash flow generation by 2021.
"Medtronic has ambitious growth plans over the next five years. Personally I am skeptical all the targets can be hit," concluded the article's author.